Abstract 455P
Background
Nutritional status and proper dietary intake have a vital role in cancer prognosis and progression. Alterations in metabolic system due to chemotherapy and cancer can lead to high prevalence of malnutrition. It can be attributable to cancer, therapy effect and decreased food intake. Malnutrition has negative impact on patients treatment, side effects, immunity, Quality of life (QOL) and prolonged hospital stay and expense. Our study aims to assess the nutritional status, timely intervention and QOL in cancer patients undergoing chemotherapy.
Methods
A prospective hospital-based multidisciplinary interventional study was conducted in 97 patients with known histological malignancies who had received chemotherapy as inpatients in oncology wards at Ramaiah hospital in Bangalore for a period of six months. Detailed interview of patients and their care-takers were analysed in structured formats. Malnutrition and QOL were assessed using PG-SGA scale and EORTC QLQ C-30 questionnaire respectively. QOL was assessed at the beginning and at the end of the chemotherapy whereas PG-SGA scale was done for all the cycles and dietary intervention was given to patients who were moderately and severely malnourished. Follow up was done for all the patients till the end of the therapy.
Results
Out of 97 patients 61% were females and 36% were males. During the chemotherapy third cycle 19.5% patients were found to be well nourished (stage A) 63% were moderately malnourished (stage B) and 17.5% were severely malnourished (stage C). After the chemotherapy sixth cycle 60% were in stage A and 34% were in stage B and 6% were in stage C. Qol was also assessed and the total score before and after the chemotherapy was found to be 54.2 + 11.46 and 46.16 + 9.77 respectively Whereas 23% of the patients showed higher score (9.8 + 3.6) in physical domain before the treatment and at the end of the treatment the score increased (22 + 4.1). Emotional domain before treatment (5.9 + 2.5) and after treatment (5.3 + 2.3) social (3.6 + 1.4 and 3.5 + 1.4) cognitive (2.04 + 0.31 and 2.04 + 0.30) and role (5.9 + 1.5 and 3.9 + 1.4).
Conclusions
Pre-emptive assessment of nutritional status and prompt dietary guidance and intervention can improve patient’s nutritional status and QOL.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Sri Prathima.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
87P - Negative to positive lymph node ratio-prognostic marker of survival in node positive rectal cancer
Presenter: Pavan Jonnada
Session: Poster display session
Resources:
Abstract
88P - The Sidra LUMC advanced colon cancer NGS cohort
Presenter: Wouter Hendrickx
Session: Poster display session
Resources:
Abstract
89P - A phase II trial of adjuvant chemoradiotherapy for patients with high-risk rectal submucosal invasive cancer after local resection
Presenter: Masaaki Noguchi
Session: Poster display session
Resources:
Abstract
90P - High MICB expression confers prognostic benefit in colorectal cancer
Presenter: Shanchao Yu
Session: Poster display session
Resources:
Abstract
91P - Adjuvant therapy for high-risk stage II or stage III colon adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study
Presenter: Chien-Hsin Chen
Session: Poster display session
Resources:
Abstract
92P - Prospective randomized controlled study comparing primary surgery versus neoadjuvant chemotherapy followed by surgery in gastric carcinoma
Presenter: Vipin Goel
Session: Poster display session
Resources:
Abstract
93P - Biomarker selection of liver metastatic colorectal patients for anti-EGFR monoclonal antibodies: A machine learning analysis
Presenter: Yijiao Chen
Session: Poster display session
Resources:
Abstract
94P - NORTH/HGCSG1003: North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer: Final analysis
Presenter: Michio Nakamura
Session: Poster display session
Resources:
Abstract
95P - Anatomical resections improve relapse-free survival in patients with KRAS/NRAS/BRAF- mutated colorectal liver metastases
Presenter: Ye Wei
Session: Poster display session
Resources:
Abstract
96P - Incidence, characteristics and prognosis in colorectal cancer with CNS metastases
Presenter: Nicola Taylor
Session: Poster display session
Resources:
Abstract